IVF and cancer risk remain a common concern. An Australian cohort of 417,984 women exposed to medically assisted reproduction found overall invasive cancer incidence comparable to the general population in the ART group. That reassuring finding does not settle every cancer-specific question or prove that treatment has no risks.
“Will this treatment give me cancer?” is an understandable question in a consultation about IVF. A useful answer needs both reassuring findings and their limits.
This question, often whispered in consultation rooms, carries the weight of decades of anecdotal anxiety. For years, the narrative has been fueled by the fear of hormonal stimulation: “Is it safe to use these drugs to produce so many eggs? Is it safe to repeatedly stimulate the ovaries?” From breast and ovarian cancer to more obscure fears regarding melanoma or thyroid cancer, the association between IVF and malignancy has grown into a widespread public concern.
Hormone-related concerns deserve evidence-based discussion rather than either dismissal or alarm.
A 2026 Australian population-based cohort included 417,984 women exposed to medically assisted reproduction. This was not a cohort in which every participant received IVF.
Digging Deeper into the Data
The ART group had an overall invasive-cancer standardized incidence ratio of 1.00 (95% CI 0.98–1.02); the IUI/ovarian-stimulation group’s was 0.99 (0.97–1.02). Some cancer-specific incidences were elevated.
The comparison was with the general population, not a randomized untreated infertility group. Underlying infertility, reproductive history and surveillance can complicate interpretation.
Reassurance is not a universal acquittal
Comparable overall incidence does not establish that every cancer-specific risk is absent or that an individual has no reason for tailored counseling.
The ART group’s median follow-up was 9.42 years. An overall ratio should not be read as proof that all long-term questions have been answered.
The result can make the conversation more concrete. It does not require patients to stop asking about personal history, specific medications or appropriate follow-up.
The goal is informed treatment, not a courtroom verdict. Good counseling makes room for reassurance without replacing uncertainty with an absolute claim.
Disclaimer: This content is provided for informational purposes, based on reporting on infertility and various public data. Medical judgments and treatment decisions must always be made in consultation with professional medical personnel. Image: AI-generated (ChatGPT, OpenAI) / Visual reference for illustrative purposes only.
The identifiable primary study
Vajdic and colleagues, JAMA Network Open 9(3):e261332, published March 10, 2026. DOI: 10.1001/jamanetworkopen.2026.1332. The observational design cannot isolate treatment causation. Cancer Incidence in Women After Medically Assisted Reproduction.
Related reading
IVF After Breast Cancer: Is the Old Taboo Giving Way to Evidence?